-
公开(公告)号:US12016896B2
公开(公告)日:2024-06-25
申请号:US17532285
申请日:2021-11-22
申请人: CORNELL UNIVERSITY
发明人: Gang Lin , Carl Nathan , Pradeep K. Singh
IPC分类号: A61K38/05 , A61K31/165 , A61K31/42 , A61K38/02 , C07C237/06 , C07C237/12 , C07C237/22 , C07C271/22 , C07C311/14 , C07C311/19 , C07D209/18 , C07D261/18 , C07K5/06
CPC分类号: A61K38/05 , A61K31/165 , A61K31/42 , A61K38/02 , C07C237/06 , C07C237/12 , C07C237/22 , C07C271/22 , C07C311/14 , C07C311/19 , C07D209/18 , C07D261/18 , C07K5/06 , C07C2601/02
摘要: The compounds of the present invention are represented by the following compounds having Formula I:
where the substituents R1, R4, L, M, X, Y, and s are as defined herein. The compounds of the present invention are also represented by the following compounds having Formula (Ia), Formula (Ib), or Formula (Ic):
where the substituents R1-R4, Rx, Ry, X, Y, and s are as defined herein.
These compounds are used in the treatment of cancer, immunologic disorders, autoimmune disorders, neurodegenerative disorders, or inflammatory disorders or for providing immunosuppression for transplanted organs or tissues.-
公开(公告)号:US11685732B2
公开(公告)日:2023-06-27
申请号:US16766890
申请日:2018-11-29
申请人: Epizyme, Inc.
IPC分类号: C07D403/12 , C07D309/06 , C07D309/08 , C07D231/12 , C07D231/56 , C07D471/10 , C07D263/28 , C07D263/50 , C07D205/04 , C07D265/30 , C07D207/08 , C07D275/03 , C07C311/19 , C07C311/32 , C07C311/49 , C07C255/00 , C07C307/02 , C07C317/50 , A61K31/40 , A61K31/18 , A61K31/165 , A61P35/00 , C07D405/12 , C07D211/24 , C07D213/54 , C07D223/04 , C07D233/64 , C07D241/04 , C07D257/04 , C07D401/12 , C07D401/14 , C07D403/14 , C07D405/14 , C07D413/12 , C07D417/12
CPC分类号: C07D405/12 , C07C311/49 , C07D205/04 , C07D207/08 , C07D211/24 , C07D213/54 , C07D223/04 , C07D231/12 , C07D233/64 , C07D241/04 , C07D257/04 , C07D265/30 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D413/12 , C07D417/12
摘要: The present disclosure provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
-
公开(公告)号:US11529355B2
公开(公告)日:2022-12-20
申请号:US17322606
申请日:2021-05-17
申请人: The Board of Supervisors of Louisiana State University and Agricultural and Mechanical College , University of Alcala de Henares , South Rampart Pharma, LLC
发明人: Nicolas Bazan , Hernan Bazan , Julio Alvarez-Builla Gomez , Dennis Paul , Carolina Burgos Garcia
IPC分类号: A61K31/5375 , A61P23/00 , A61K31/18 , A61K31/40 , A61K31/4402 , A61K31/495 , A61K45/06 , A61P29/00 , C07C311/19
摘要: This invention is directed to compositions, methods and kits that can be used for the treatment or amelioration of pain and fever.
-
公开(公告)号:US20220356148A1
公开(公告)日:2022-11-10
申请号:US17361246
申请日:2021-06-28
申请人: HAPLOGEN GMBH
发明人: Wolfgang Fischl , Mark Whittaker , Christopher John Yarnold , Jean-Francois Pons , Mark Anthony Kerry , Patricia Leonie Amouzegh , Inaki Morao , Peter Neville Ingram , Ewa Iwona Chudyk
IPC分类号: C07C235/74 , C07D309/04 , C07D309/14 , C07D261/18 , C07D205/04 , C07D211/26 , C07D307/14 , C07C311/19 , C07D207/27 , C07C237/22 , C07C311/13 , C07C311/29 , C07C271/24 , C07C311/06 , A61P31/14 , C07C311/03 , C07C311/10 , C07D207/26 , C07D215/14 , C07D233/64 , C07D241/12 , C07D401/12 , C07D403/06 , C07D403/12 , C07D405/06 , C07D417/12
摘要: The present invention relates to novel compounds of general Formula II: wherein the groups X, and R1 to R4 have the meanings given in the description, to a process for preparing these compounds and to their use for treating, preventing or ameliorating viral infections and diseases which are associated with PLA2G16.
-
公开(公告)号:US20220204497A1
公开(公告)日:2022-06-30
申请号:US17599931
申请日:2020-03-30
申请人: MEDICINAL BIOCONVERGENCE RESEARCH CENTER , DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
发明人: Sunghoon KIM , Dae Gyu KIM , Kyeong LEE , Minkyoung KIM
IPC分类号: C07D417/12 , A61P35/02 , C07D413/14 , C07D413/12 , C07D413/04 , C07D409/12 , C07D401/04 , C07D401/12 , C07D403/06 , C07D405/12 , C07D333/34 , C07D295/13 , C07D295/135 , C07D295/192 , C07D317/68 , C07D285/135 , C07D277/46 , C07D277/40 , C07D273/01 , C07D261/14 , C07D207/08 , C07D209/20 , C07D211/14 , C07D213/75 , C07D213/81 , C07D233/64 , C07D235/06 , C07D241/44 , C07C311/19 , C07C317/46 , C07C271/28 , C07C275/28 , C07C233/83
摘要: The present invention pertains to a novel compound having anticancer activity, and a method for producing same, and more specifically, to a novel compound that exhibits excellent anticancer activity by inhibiting the expression of AIMP2-DX2, and a method for producing same. The compound represented by chemical formula 1 according to the present invention is highly effective in inhibiting the expression of AIMP2-DX2, and thus can be very advantageously used for the development of agents for treating various diseases, in particular cancer, caused by AIMP2-DX2.
-
公开(公告)号:US20220089531A1
公开(公告)日:2022-03-24
申请号:US17416175
申请日:2019-12-20
发明人: Patrick Thomas Gunning , Siawash Ahmar , David Rosa , Gary Tin , Mulu Geletu , Ji Sung Park , Elvin D. De Araujo
IPC分类号: C07C311/19 , A61P35/00
摘要: The present invention relates to novel compounds, compositions containing same and methods for inhibiting STAT3 and/or STAT5 activity or for the treatment of a cell proliferative disorder such as a cancer using a compound of formula I or a pharmaceutically acceptable salt, solvate or hydrate thereof, wherein R and R1, different, are selected from the group consisting of wherein when one of R and R1 is a —H, the other of R and R1 is a cyclopentyl moiety, R2 is a benzyl substituted with 1-5 halogens, preferably —Cl or —F, and R3 is selected from the group consisting of —H or —OH.
-
公开(公告)号:US11123316B2
公开(公告)日:2021-09-21
申请号:US16843215
申请日:2020-04-08
IPC分类号: A61K31/18 , C07K17/06 , A61K51/10 , C07C259/06 , C07C309/14 , C07C311/19 , C07C311/29 , C07C311/42 , C07C311/46 , C07C323/60 , C07D207/48 , C07D211/60 , C07D211/96 , C07D213/42 , C07D213/74 , C07D213/89 , C07D215/36 , C07D223/06 , C07D277/06 , C07D277/80 , C07D279/12 , C07D295/13 , C07D309/06 , C07D401/12 , C07D405/12 , C07D413/12 , C07D453/06 , C07D471/08 , C07D487/08
摘要: The invention discussed in this application relates to hydroxamic acid-based compounds that are useful as imaging agents when bound to an appropriate metal centre, particularly for the imaging of tumours.
-
公开(公告)号:US20210261503A1
公开(公告)日:2021-08-26
申请号:US16614272
申请日:2018-05-17
IPC分类号: C07C311/19 , C07C381/00 , C07C69/36 , C07C69/675 , C07C227/06
摘要: In one aspect, the present disclosure provides methods of preparing a secondary amine. In some embodiments, the secondary amine comprises two different groups or two identifical groups. Also provided herein are compositions for use in the preparation of the secondary amine.
-
公开(公告)号:US20210246103A1
公开(公告)日:2021-08-12
申请号:US17238535
申请日:2021-04-23
IPC分类号: C07C275/16 , C07B59/00 , C07C275/30 , C07C311/19 , C07D213/38 , C07C275/24 , A61K39/385
摘要: Compounds of Formula (Ia) wherein R is a C6-C12 substituted or unsubstituted aryl, a C6-C12 substituted or unsubstituted heteroaryl, a C1-C6 substituted or unsubstituted alkyl or —NR′R′, Q is C(O), O, NR′, S, S(O)2, C(O)2 (CH2)p Y is C(O), O, NR′, S, S(O)2, C(O)2 (CH2)p Z is H or C1-C4 alkyl, R′ is H, C(O), S(O)2, C(O)2, a C6-C12 substituted or unsubstituted aryl, a C6-C12 substituted or unsubstituted heteroaryl or a C1-C6 substituted or unsubstituted alkyl, when substituted, aryl, heteroaryl and alkyl are substituted with halogen, C6-C12 heteroaryl, —NR′R′ or COOZ, which have diagnostic and therapeutic properties, such as the treatment and management of prostate cancer and other diseases related to NAALADase inhibition. Radiolabels can be incorporated into the structure through a variety of prosthetic groups attached at the X amino acid side chain via a carbon or hetero atom linkage.
-
公开(公告)号:US11007199B2
公开(公告)日:2021-05-18
申请号:US16738439
申请日:2020-01-09
申请人: The Board of Supervisors of Louisiana State University and Agricultural and Mechanical College , UNIVERSITY OF ALCALA DE HENARES , South Rampart Pharma, LLC
发明人: Nicolas Bazan , Hernan Bazan , Julio Alvarez-Builla Gomez , Dennis Paul , Carolina Burgos Garcia
IPC分类号: A61K31/18 , A61P29/00 , C07C311/19 , A61K31/5375 , A61P23/00 , A61K31/40 , A61K31/4402 , A61K31/495 , A61K45/06
摘要: This invention is directed to compositions, methods and kits that can be used for the treatment or amelioration of pain and fever.
-
-
-
-
-
-
-
-
-